Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.
Róbak T, Gora-Tybor J, Krykowski E, Walewski JA, Borawska A, Pluźańska A, Potemski P, Hellmann A, Zaucha JM, Konopka L, Ceglarek B, Durźyński T, Sikorska A, Michalak K, Urasiński J, Opalińska J, Dmoszyńska A, Adamczyk-Cioch MB, Kuratowska Z, Dwilewicz-Trojaczek J, Boguradzki P, Deren M, Maj S, Grieb P. Róbak T, et al. Among authors: ceglarek b. Leuk Lymphoma. 1997 Jun;26(1-2):99-105. doi: 10.3109/10428199709109163. Leuk Lymphoma. 1997. PMID: 9250793 Clinical Trial.
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
Robak T, Błasinka-Morawiec M, Krykowski E, Kasznicki M, Płuzanska A, Potemski P, Hellmann A, Zaucha JM, Lewandowski K, Dmoszynska A, Hansz J, Komarnicki M, Konopka L, Durzynski T, Ceglarek B, Sikorska A, Kotlarek-Haus S, Mazur G, Urasinski I, Zdziarska B, Maj S, Kopec I, Skotnicki AB, Dwilewicz-Trojaczek J, Grieb P, et al. Robak T, et al. Among authors: ceglarek b. Leuk Lymphoma. 1996 Aug;22(5-6):509-14. doi: 10.3109/10428199609054790. Leuk Lymphoma. 1996. PMID: 8882965 Clinical Trial.
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia.
Robak T, Błoński JZ, Kasznicki M, Góra-Tybor I, Dwilewicz-Trojaczek J, Boguradzki P, Konopka L, Ceglarek B, Sułek J, Kuliczkowski K, Wołowiec D, Stella-Hołowiecka B, Skotnicki AB, Nowak W, Moskwa-Sroka B, Dmoszyńska A, Calbecka M. Robak T, et al. Among authors: ceglarek b. Leukemia. 2001 Oct;15(10):1510-6. doi: 10.1038/sj.leu.2402216. Leukemia. 2001. PMID: 11587207 Clinical Trial.
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M, Dwilewicz-Trojaczek J, Wiater E, Zdunczyk A, Dybowicz J, Dmoszynska A, Wojtaszko M, Zdziarska B, Calbecka M, Kostyra A, Hellmann A, Lewandowski K, Stella-Holowiecka B, Sulek K, Gawronski K, Skotnicki AB, Nowak W, Zawilska K, Molendowicz-Portala L, Kloczko J, Sokolowski J, Warzocha K, Seferynska I, Ceglarek B, Konopka L. Robak T, et al. Among authors: ceglarek b. Blood. 2007 May 1;109(9):3672-5. doi: 10.1182/blood-2006-08-042929. Epub 2007 Jan 5. Blood. 2007. PMID: 17209059 Free article. Clinical Trial.
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients.
Robak T, Bloński JZ, Kasznicki M, Konopka L, Ceglarek B, Dmoszyńska A, Soroka-Wojtaszko M, Skotnicki AB, Nowak W, Dwilewicz-Trojaczek J, Tomaszewska A, Hellmann A, Lewandowski K, Kuliczkowski K, Potoczek S, Zdziarska B, Hansz J, Kroll R, Komarnicki M, Holowiecki J, Grieb P. Robak T, et al. Among authors: ceglarek b. Br J Haematol. 2000 Feb;108(2):357-68. doi: 10.1046/j.1365-2141.2000.01850.x. Br J Haematol. 2000. PMID: 10691866 Free article. Clinical Trial.
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
Robak T, Bloński JZ, Kasznicki M, Blasińska-Morawiec M, Krykowski E, Dmoszyńska A, Mrugala-Spiewak H, Skotnicki AB, Nowak W, Konopka L, Ceglarek B, Maj S, Dwilewicz-Trojaczek J, Hellmann A, Urasiński I, Zdziarska B, Kotlarek-Haus S, Potoczek S, Grieb P. Robak T, et al. Among authors: ceglarek b. Blood. 2000 Oct 15;96(8):2723-9. Blood. 2000. PMID: 11023504 Free article. Clinical Trial.
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
Robak T, Blonski JZ, Gora-Tybor J, Kasznicki M, Konopka L, Ceglarek B, Komarnicki M, Lewandowski K, Hellmann A, Lewandowski K, Moskwa A, Dmoszyńska A, Sokołowska B, Dwilewicz-Trojaczek A, Tomaszewska A, Sułek K, Całbecka M. Robak T, et al. Among authors: ceglarek b. Eur J Cancer. 2004 Feb;40(3):383-9. doi: 10.1016/j.ejca.2003.09.031. Eur J Cancer. 2004. PMID: 14746857
[Chronic eosinophilic leukemia].
Kredzielak-Manikowska I, Traczyk Z, Ceglarek B, Sikorska A, Brycz-Witkowska J, Stańczak H, Wozniak J, Konopka L. Kredzielak-Manikowska I, et al. Among authors: ceglarek b. Pol Arch Med Wewn. 2000 Jan-Feb;103(1-2):67-71. Pol Arch Med Wewn. 2000. PMID: 11236261 Polish.
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.
Blonski JZ, Robak T, Chojnowski K, Gora-Tybor J, Warzocha K, Ceglarek B, Seferynska I, Calbecka M, Kostyra A, Stella-Holowiecka B, Kloczko J, Dmoszynska A, Kowal M, Lewandowski K, Dwilewicz-Trojaczek J, Wiater E, Kuliczkowski K, Potoczek S, Hellmann A, Mital A, Skotnicki A, Nowak W, Sulek K, Zawilska K, Trelinski J. Blonski JZ, et al. Among authors: ceglarek b. Eur J Haematol. 2013 Jul;91(1):1-9. doi: 10.1111/ejh.12112. Epub 2013 Apr 19. Eur J Haematol. 2013. PMID: 23521128 Clinical Trial.
16 results